# Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

> **NCT00297856** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 10000 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Acellular Pertussis

## Interventions

- **BIOLOGICAL:** Boostrix®
- **BIOLOGICAL:** Td (Tetanus diphtheria) vaccine

## Key facts

- **NCT ID:** NCT00297856
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 10000 (ACTUAL)
- **Last updated:** 2014-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297856, "Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00297856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*